Baxter International Inc.

About Baxter International Inc.
Baxter International Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company's global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter's 50,000 employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. 

At Baxter, sustainability means creating lasting social, environmental and economic value by addressing the needs of the company’s wide-ranging stakeholder base. The company's sustainability efforts support Baxter's mission to apply innovative science in the development of products and therapies that save and sustain patients' lives.

Research, Reports & Publications | Baxter International Inc.

Baxter Releases Annual Corporate Responsibility Report; Announces Progress Toward Social and Environmental 2020 Goals

Jul 20, 2017 3:40 PM ET

Baxter International Inc. (NYSE: BAX), a global medical products company, today announced the publication of its 18th annual corporate responsibility report. Entitled Making a Meaningful Difference, the report details Baxter’s commitment to delivering environmental, social and economic value to the communities and constituencies the company serves in support of its mission to “Save and Sustain Lives.”